Background
We aimed to retrospectively analyze the clinical and surgical outcomes following posterior lumbar interbody fusion plus pedicle screw fixation compared to midline lumbar fusion in patients aged ≥ 80 years with degenerative lumbar spine disease.
Methods
The study group comprised 68 patients aged ≥ 80 who underwent degenerative lumbar spinal surgery at our spine center between January 2011 and December 2020. Among them, 24 underwent posterior lumbar interbody fusion plus pedicle screw fixation, and the remaining 44 underwent midline lumbar fusion.
Results
No significant intergroup differences were found in age, sex ratio, follow-up duration, or surgical level. The Visual Analog Scale for lower back pain was significantly different between the two groups at 7 days after surgery (P = 0.049). The Oswestry Disability Index was significantly different between the two groups at 7 days after surgery (P = 0.05). The estimated blood loss and operative time differed significantly (P < 0.05). There was a statistically significant difference in the postoperative morbidities between the groups (P = 0.049).
Conclusions
Although the clinical outcomes were not significantly different between the two groups, the perioperative morbidity was better in the midline lumbar fusion group. Therefore, we conclude that midline lumbar fusion is not inferior to posterior lumbar interbody fusion plus pedicle screw fixation if there is a need for fusion in elderly patients over octogenarian.
Trial registration
The Institutional Review Board of National Health Insurance Service Ilsan Hospital approved this study (2022-01-027), and the requirement of informed consent was waived due to the study's retrospective nature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.